1858B |
Drugs of Abuse (10 Panel) and Alcohol Screen, Blood |
1858FL |
Drugs of Abuse (10 Panel) and Alcohol Screen, Fluid |
1858SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
1858TI |
Drugs of Abuse (10 Panel) and Alcohol Screen, Tissue |
1858U |
Drugs of Abuse (9 Panel) and Alcohol Screen, Urine |
1861B |
Drugs of Abuse Screen (7 Panel), Blood |
1861U |
Drugs of Abuse Screen (6 Panel), Urine |
1864B |
Drugs of Abuse Screen (11 Panel), Blood |
1864FL |
Drugs of Abuse Screen (11 Panel), Fluid |
1864ME |
Drugs of Abuse Screen (10 Panel), Meconium |
1864SP |
Drugs of Abuse Screen (11 Panel), Serum/Plasma |
1864TI |
Drugs of Abuse Screen (11 Panel), Tissue |
1864U |
Drugs of Abuse Screen (10 Panel), Urine |
1874B |
Drug Screen (10 Panel), Blood |
1874U |
Drug Screen (9 Panel), Urine |
1876B |
Drug Screen - Expanded, Blood |
1876FL |
Drug Screen - Expanded, Fluid |
1876SP |
Drug Screen - Expanded, Serum/Plasma |
1876U |
Drug Screen - Expanded, Urine |
2540B |
LSD Trace Analysis, Blood |
2540SP |
LSD Trace Analysis, Serum/Plasma |
2540U |
LSD Trace Analysis, Urine |
2541B |
LSD Screen, Blood |
2541SP |
LSD Screen, Serum/Plasma |
2541U |
LSD Screen, Urine |
2584B |
Methylenedioxyamphetamine, Blood |
2584SP |
Methylenedioxyamphetamine, Serum/Plasma |
2584U |
Methylenedioxyamphetamine, Urine |
2585B |
Methylenedioxymethamphetamine and Metabolite, Blood |
2585SP |
Methylenedioxymethamphetamine and Metabolite, Serum/Plasma |
2585U |
Methylenedioxymethamphetamine and Metabolite, Urine |
2679B |
Mescaline, Blood |
2679SP |
Mescaline, Serum/Plasma |
2679U |
Mescaline, Urine |
2680B |
Mescaline Screen, Blood |
2680SP |
Mescaline Screen, Serum/Plasma |
2680U |
Mescaline Screen, Urine |
3532B |
Phencyclidine Screen, Blood |
3532FL |
Phencyclidine Screen, Fluid |
3532SP |
Phencyclidine Screen, Serum/Plasma |
3532U |
Phencyclidine Screen, Urine |
4029B |
Psilocybin as Psilocin (Qualitative), Blood |
4029SP |
Psilocybin as Psilocin (Qualitative), Serum/Plasma |
4029U |
Psilocybin as Psilocin (Qualitative), Urine |
6904ME |
Drugs of Abuse Screen (7 Panel), Meconium |
6925H |
Phencyclidine Screen, Hair |
6946H |
Drugs of Abuse Screen (9 Panel), Hair |
8050U |
Postmortem, Urine Screen Add-On (6-MAM Quantification only) (Forensic) Overview: Add-On Test |
8061B |
Postmortem, Basic w/o Alcohol, Blood (Forensic) |
8061TI |
Postmortem, Basic w/o Alcohol, Tissue (Forensic) |
8061U |
Postmortem, Basic w/o Alcohol, Urine (Forensic) |
8070U |
DUID/DRE Panel (w/Alcohol), Urine (Forensic) |
8071U |
DUID/DRE Panel, Urine (Forensic) |
8083B |
Postmortem, Basic w/Vitreous Alcohol and 6-MAM Confirmation, Blood (Forensic) |
8098B |
Drug Screen (GC/MS), Blood |
8098SP |
Drug Screen (GC/MS), Serum/Plasma |
8098U |
Drug Screen (GC/MS), Urine |
8104B |
Postmortem, Fire Death Screen, Blood (Forensic) |
8150B |
DUID/DRE Panel, Blood (Forensic) |
8151B |
DUID/DRE Panel (w/Alcohol), Blood (Forensic) |
8158B |
DUID/DRE Expanded Drug Screen (w/Alcohol), Blood (Forensic) |
8159B |
DUID/DRE Expanded Drug Screen, Blood (Forensic) |
8758B |
Hallucinogens Screen, Blood |
8758SP |
Hallucinogens Screen, Serum/Plasma |
8758U |
Hallucinogens Screen, Urine |
8761B |
Phencyclidine, Blood |
8761FL |
Phencyclidine, Fluid |
8761ME |
Phencyclidine (Qualitative), Meconium |
8761SP |
Phencyclidine, Serum/Plasma |
8761TI |
Phencyclidine, Tissue |
8761U |
Phencyclidine, Urine |
8896OF |
Phencyclidine and Dextromethorphan (Qualitative), Oral Fluid (Saliva) |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9293B |
Methylenedioxymethamphetamine and Metabolite Screen, Blood |
9293SP |
Methylenedioxymethamphetamine and Metabolite Screen, Serum/Plasma |
9293U |
Methylenedioxymethamphetamine and Metabolite Screen, Urine |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |